Latest Breaking News On - Oric pharmaceuticals inc - Page 5 : comparemela.com

Baystreet ca - ORIC Hails Private Placement

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) saw its shares shoot up Monday. The San Francisco-based clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that it has agreed to .

Frazier life sciencesOric pharmaceuticals incSan francisco basedViking global investorsCommodore capitalVenrock healthcare capital partners

ORIC Pharmaceuticals (ORIC) Prices 12 5M Share Offering at $10/sh

ORIC Pharmaceuticals (ORIC) Prices 12 5M Share Offering at $10/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrazier life sciencesOric pharmaceuticals incExchange commissionViking global investorsCommodore capitalVenrock healthcare capital partnersSecurities act

ORIC Pharmaceuticals, Inc (NASDAQ:ORIC) Receives $16 14 Consensus Target Price from Analysts

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been given a consensus recommendation of “Buy” by the seven research firms that are presently covering the company, Marketbeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have updated their coverage on the stock […]

United statesJacob chackoPratiks multaniSecurities exchange commissionPharmaceuticals company profileDeutsche bankVanguard group incEuclidean capitalPharmaceuticals tradingAmerican century companies incAlkeon capital managementPharmaceuticals incOric pharmaceuticals incPharmaceuticals dailyGet free reportExchange commission

Insider Selling: ORIC Pharmaceuticals, Inc (NASDAQ:ORIC) CEO Sells $124,744 62 in Stock

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) CEO Jacob Chacko sold 14,539 shares of ORIC Pharmaceuticals stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $8.58, for a total value of $124,744.62. Following the completion of the sale, the chief executive officer now directly owns 808,544 […]

United statesJacob chackoPharmaceuticals incAmeritas investment partners incOric pharmaceuticals incPharmaceuticals dailyAcadian asset managementRoyal bankGroup one tradingPharmaceuticals stockPharmaceuticals company profileGet free reportInvestment partnersOric pharmaceuticalsNasdaq oricInsider trading

Jacob Chacko Sells 14,539 Shares of ORIC Pharmaceuticals, Inc (NASDAQ:ORIC) Stock

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) CEO Jacob Chacko sold 14,539 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $8.58, for a total transaction of $124,744.62. Following the completion of the transaction, the chief executive officer now owns 808,544 […]

United statesJacob chackoGroup one tradingRoyal bankPharmaceuticals dailyPharmaceuticals incOric pharmaceuticals incPharmaceuticals stockPharmaceuticals company profileAcadian asset managementSecurities exchange commissionAmeritas investment partners incGet free reportExchange commissionInvestment partnersAsset management